Omkar Pharmachem Ltd
Omkar Pharmachem Ltd (OMKARPH) last traded at ₹11, a market capitalisation of ₹11.1 crore, on a P/E of 124. Over the past 52 weeks the stock has ranged between ₹11 and ₹29.7. Omkar Pharmachem Ltd last reported results for the quarter ended Jun 2026, with sales of ₹0.09 crore and net profit of ₹-0.01 crore. Figures are as of 25 Aug 2026 and are not real time.
Omkar Pharmachem Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Omkar Pharmachem Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹0.09 cr, down 35.7% from ₹0.14 cr a year earlier. Net profit swung to a loss of ₹0.01 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.11 | 0.09 | 0.09 |
| Expenses | 0.05 | 0.05 | 0.07 | 0.1 | 0.07 | 0.07 | 0.07 | 0.1 |
| Operating profit | 0.09 | 0.09 | 0.07 | 0.04 | 0.07 | 0.04 | 0.02 | -0.01 |
| OPM % | 64.29% | 64.29% | 50.00% | 28.57% | 50.00% | 36.36% | 22.22% | -11.11% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.09 | 0.09 | 0.05 | 0.04 | 0.07 | 0.04 | 0.02 | -0.01 |
| Tax % | 0.00% | 0.00% | 140.00% | 25.00% | 28.57% | 25.00% | 0.00% | 0.00% |
| Net profit | 0.09 | 0.08 | -0.02 | 0.03 | 0.05 | 0.03 | 0.02 | -0.01 |
| EPS (₹) | 0.09 | 0.08 | -0.02 | 0.03 | 0.05 | 0.03 | 0.02 | -0.01 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Omkar Pharmachem Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0.27 | 0.54 | 0.54 | 0.54 | 0.54 | 0.47 | 0.43 |
| Operating profit | 0.03 | 0.27 | 0.32 | 0.29 | 0.3 | 0.16 | 0.12 |
| OPM % | 11.11% | 50.00% | 59.26% | 53.70% | 55.56% | 34.04% | 27.91% |
| Net profit | 0.22 | 0.18 | 0.2 | 0.19 | 0.2 | 0.12 | 0.09 |
| EPS (₹) | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 | 0.12 | 0.09 |
TTM is the trailing twelve months to the most recent quarter.
Omkar Pharmachem Ltd growth and returns
- 10 Years
- %
- 5 Years
- 12%
- 3 Years
- -5%
- TTM
- -23%
- 10 Years
- 12%
- 5 Years
- -11%
- 3 Years
- -16%
- TTM
- -50%
- 10 Years
- %
- 5 Years
- -11%
- 3 Years
- -16%
- 1 Year
- -55%
- 10 Years
- 0%
- 5 Years
- 2%
- 3 Years
- 1%
- Last Year
- 1%
Omkar Pharmachem Ltd shareholding pattern
Promoters held 0.03% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Public | 99.97% | 99.97% | 99.97% | 99.97% | 99.97% | 99.97% | 99.97% | 99.97% |
| No. of shareholders | 3,608 | 3,609 | 3,611 | 3,619 | 3,618 | 3,618 | 3,617 | 3,669 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Omkar Pharmachem Ltd corporate filings
- Dear Sir, Please find publication of results for the quarter ended 30.06.2026.Company Updatelow impact
Cruxal's analysis: Omkar Pharmachem Limited has released its unaudited financial results for the quarter…
Read the full analysis - Dear Sir, Pursuant to provisions of Reg. 33 of SEBI (LODR)Regulations, 2015, please find Unaudited Financial Results for the Quarter ended on 30.06.2026Resultlow impact
Cruxal's analysis: Omkar Pharmachem Limited reported a net loss of 1 lakh INR for the quarter ended 30 June…
Read the full analysis - Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 13 August, ....Board Meetinglow impact
Cruxal's analysis: Omkar Pharmachem Limited reported a net loss of 1 lakh for the quarter ended 30 June…
Read the full analysis - Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial result ....Board Meetinglow impact
Cruxal's analysis: Omkar Pharmachem Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Omkar Pharmachem Ltd
Cruxal reads every Omkar Pharmachem Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.